[Genetics 101] Assessing Patients for Hereditary Cancer Risk 

We know that not all cancer is hereditary, so how do we identify those patients who might be at risk for hereditary cancer and could benefit from genetic testing?  This course will review tools and skills used to identify at-risk patients as well as considerations for patients as they decide whether or not to pursue genetic testing. 

57dee625eacec
Emily Dalton
Director, Genomic Science Liaisons
Emily Dalton is the Director of the Genomic Science Liaison team at Ambry Genetics, where she oversees a field-based team of clinical and technical experts in Ambry’s offerings. During her tenure at Ambry, Emily has presented at a number of domestic and international conferences and cultivated research collaborations with major academic medical centers.  Prior to […]

Emily earned a BA in Cell and Molecular Biology from Skidmore College in Saratoga Springs, New York. She then attended the Boston University School of Medicine Genetic Counseling program, where she earned her Master’s in Genetic Counseling.  She is a current member of the BU Program Advisory Board, and has also stayed involved with the BUGC Program through course coordination, guest lecturing, and student capstone involvement.  Soon after graduating, Emily started her position as a cancer genetic counselor at Dana-Farber Cancer Institute in Boston, MA, where she had both clinical and research responsibilities.  She joined Ambry Genetics in 2013 as an Oncology Genetic Specialist, and is currently the Director of the Genetic Specialist team. 

58c195909c64f
Selvi Palaniappan
Genetic Specialist II
Selvi Palaniappan is a certified genetic counselor and Oncology Genetic Specialist at Ambry Genetics. Prior to gaining her M.S. in Genetic Counseling from University of California, Irvine, Selvi was a researcher at the Howard Hughes Medical Institute at University of Michigan. She joined Ambry after more than 20 years of working clinically at Emory University, Vanderbilt […]

Selvi Palaniappan is a certified genetic counselor and Oncology Genetic Specialist at Ambry Genetics. Prior to gaining her M.S. in Genetic Counseling from University of California, Irvine, Selvi was a researcher at the Howard Hughes Medical Institute at University of Michigan. She joined Ambry after more than 20 years of working clinically at Emory University, Vanderbilt Ingram Cancer Center, and most recently, developing a cancer genetics program at Northside Hospital in Atlanta, Georgia.